Daily Archives: May 27, 2020
WHO Manifesto for a Healthy Recovery from COVID-19
27 May, 2020 | 02:47h | UTCWHO Manifesto for a healthy recovery from COVID-19 – World Health Organization
WHO: Revealing the Toll of COVID-19 – A Technical Package for Rapid Mortality Surveillance and Epidemic Response
27 May, 2020 | 02:48h | UTC
Related Commentary on Twitter
Countries need real-time mortality data for an effective #COVID19 response.
WHO together with @VitalStrat & @AfricaCDC released a new technical package on rapid mortality surveillance https://t.co/NeIZFNW774#WorldHealthData pic.twitter.com/5HcDjfXxBD
— World Health Organization (WHO) (@WHO) May 25, 2020
Perspective: Fast and Frugal Innovations in Response to the COVID-19 Pandemic
27 May, 2020 | 02:33h | UTCFast and frugal innovations in response to the COVID-19 pandemic – Nature Medicine
Related Commentary on Twitter
COVID-19 has precipitated 'fast and frugal' innovation. Regulatory barriers temporarily eased. All sorts of things from hydroxychloroquine to ventilator multipliers have been introduced without full evaluation. Benefits – and risks – reviewed here. https://t.co/uE5TIsGj9Y
— Trisha Greenhalgh ? (@trishgreenhalgh) May 26, 2020
“Is It Safe for Me to Go to Work?” Risk Stratification for Workers during the Covid-19 Pandemic
27 May, 2020 | 02:39h | UTC
Study: Loss of Smell and Taste in 2013 Patients with Mild to Moderate COVID-19
27 May, 2020 | 02:35h | UTC
CDC Updated Guidance: When You Can be Around Others After You Had or Likely Had COVID-19
27 May, 2020 | 02:37h | UTC“I think or know I had COVID-19, and I had symptoms.”
You can be with others after:
- 3 days with no fever AND
- Symptoms improved AND
- 10 days since symptoms first appeared”
Perspective: The Totality of the Evidence, by Dr. John Ioannidis
27 May, 2020 | 02:29h | UTCThe Totality of the Evidence – Boston Review
See other interesting perspectives from the Boston Review: Models v. Evidence AND Good Science Is Good Science
“Given what we know now, it is reasonable to consider alternatives to population-wide lockdown, even as we focus on protecting those most at risk and support health care systems to care for patients who are sick.”
Clinical Guidance: Advanced Pulmonary and Cardiac Support of COVID-19 Patients
27 May, 2020 | 02:27h | UTC
Just the Facts: What Drugs are Safe and Effective for COVID-19?
27 May, 2020 | 02:31h | UTCRelated Guidelines: NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health AND Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection
“Apart from supportive care, there are no current effective therapeutics for COVID-19”
A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2
27 May, 2020 | 02:22h | UTCA Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2 – The FEBS Journal
Reasons to Worry Less About the Explosion of Preprints
27 May, 2020 | 02:24h | UTCReasons to Worry Less About the Explosion of Preprints – Absolutely Maybe Blog
Preprinting a Pandemic: The Role of Preprints in the COVID-19 Pandemic
27 May, 2020 | 02:25h | UTCPreprinting a pandemic: the role of preprints in the COVID-19 pandemic – bioRxiv
Duration of Prone Position Sessions: A Prospective Cohort Study
27 May, 2020 | 02:20h | UTCDuration of prone position sessions: a prospective cohort study – Annals of Intensive Care
Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19
27 May, 2020 | 02:21h | UTC
Lyme Borreliosis: Diagnosis and Management
27 May, 2020 | 02:19h | UTCLyme borreliosis: diagnosis and management – The BMJ (free for a limited period)
Short Review: Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020
27 May, 2020 | 02:18h | UTCUsing Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020 – JAMA (free for a limited period)
Randomized Trial: Antihypertensive Medication Reduction vs. Usual Care Among Older Adults Taking Multiple Antihypertensive Medications
27 May, 2020 | 02:16h | UTC
Related Commentary on Twitter
Less is more? Our new trial suggests #deprescribing #bloodpressure lowering medications is safe in the short-term in older people with frailty and multimorbidity – see thread for details https://t.co/fLf2Vv42hB #hypertension #RCT @richardjmcmanus @jenniaburt @HomeUrs29 @prof_mant pic.twitter.com/HfScHju6HS
— James Sheppard (@jamessheppard48) May 26, 2020
Meta-Analysis: Vasopressin or Its Analogs are Not Associated with Reduced Mortality Compared to Catecholamines Alone in Patients with Septic Shock
27 May, 2020 | 02:13h | UTCRelated Review: Vasopressin and its analogues in shock states: a review – Annals of Intensive Care (free)
The Challenge of Implementing “Less is More” Medicine: A European Perspective
27 May, 2020 | 02:14h | UTC
[Abstract Only] Study: Estimating the Lifetime Benefits of a Multi-drug Regimen for Heart Failure
27 May, 2020 | 02:41h | UTCEstimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials – The Lancet (link to abstract – $ for full-text)
Related Commentary on Twitter
NEW Research—Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trialshttps://t.co/XjRPvdU7tK pic.twitter.com/ZAjynxPdAK
— The Lancet (@TheLancet) May 22, 2020
Wed May 27 – 10 Stories of The Day!
27 May, 2020 | 02:50h | UTC
2 – WHO Manifesto for a healthy recovery from COVID-19 – World Health Organization
“I think or know I had COVID-19, and I had symptoms”.
You can be with others after:
- 3 days with no fever AND
- Symptoms improved AND
- 10 days since symptoms first appeared”
Related Guidelines: NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health AND Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection
“Apart from supportive care, there are no current effective therapeutics for COVID-19”
7 – The Totality of the Evidence – Boston Review
See other interesting perspectives from the Boston Review: Models v. Evidence AND Good Science Is Good Science
“Given what we know now, it is reasonable to consider alternatives to population-wide lockdown, even as we focus on protecting those most at risk and support health care systems to care for patients who are sick.”
10 –COVID-19 Updates / 27 May 2020 Edition
27 May 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)